InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Talamo Joseph. Insider active across 2 companies, notably Caladrius Biosciences, INC.. Cumulatively, 4 disclosures have been published. Activity tracked since 30 June 2025. The latest transaction was disclosed on 31 December 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Talamo Joseph is a declarant linked to INTENSITY THERAPEUTICS, INC. as Chief Financial Officer, and to Caladrius Biosciences, INC. with the role See Remarks. He has 4 filings in total, and in the recent filings available the transactions are attributions, with publication dates from 2016-01-27 to 2026-01-05.